Role of matrix metalloproteinase-9 in endothelial apoptosis in chronic heart failure in mice

Journal of Applied Physiology

Volumn 99, Issue 6, 2005, Pages 2398-2405

  Ovechkin, Alexander V ^a   Tyagi, Neetu ^a   Rodriguez, Walter E ^a   Hayden, Melvin R ^a   Moshal, Karni S ^a   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

A disintegrin and metalloproteinase 12; Arteriovenous fistula; Congestive heart failure; Connexin 43; Endocardial dysfunction; Extracellular matrix remodeling; Protease activated receptors 1; Terminal deoxynucleotidyl nick end labeling

Indexed keywords

ADAM 12 PROTEIN; CASPASE 3; COMPLEMENTARY DNA; CONNEXIN 43; DISINTEGRIN; GELATINASE B; MACROPHAGE ELASTASE; MESSENGER RNA; PROTEIN; PROTEINASE ACTIVATED RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA PRESSURE; APOPTOSIS; ARTERIOVENOUS FISTULA; ARTICLE; CHRONIC DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEART LEFT VENTRICLE PRESSURE; MALE; MOUSE; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRESSURE MEASUREMENT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CHRONIC DISEASE; HEART FAILURE, CONGESTIVE; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT; MYOCYTES, CARDIAC;

EID: 28044449709     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00442.2005     Document Type: Article

References (31)

1. Braunwald E and Bristow MR. Congestive heart failure: fifty years of progress. Circulation 102: 14-23, 2000.
2. Brewer J, Kisselgof A, and Martin T. Genetic variability in pulmonary physiological, cellular, and antibody responses to antigen in mice. Am J Respir Crit Care Med 160: 1150-1156, 1999.
3. Chancey AL, Brower GL, Peterson JT, and Janicki JS. Effects of matrix metalloproteinase inhibition on ventricular remodeliung due to volume overload. Circulation 105: 1983-1988, 2002.
4. Cox MJ, Sood HS, Hunt MJ, Chandler D, Henegar JR, Aru GM, and Tyagi SC. Apoptosis in the left ventricle of chronic volume overload causes endocardial endothelial dysfunction in rats. Am J Physiol Heart Circ Physiol 282: H1197-H1205, 2002.
5. De Simone G, Wallerson DC, Volpe M, and Devereux RB. Echocardiographic measurements of LV mass and volume in normal and hypertensive rats. Am J Hypertens 3: 688-696, 1999.
6. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde L, Schoen F, Kelly R, Werb Z, Libby P, and Lee R. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106: 55-62, 2000.
7. Garcia R and Diebold S. Simple, rapid, and effective method of producing aortocaval shunts in the rats. Cardiovasc Res 24: 430-432, 1990.
8. Goette A, Juenemann G, Peters B, Klein HU, Roessner A, Huth C, and Rocken C. Determinants and consequences of atrial fibrosis in patients undergoing open heart surgery. Cardiovasc Res 54: 390-396, 2002.
9. Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin G, Cleutjens JP, Shipley M, Angellilo A, Levi M, Nube O, Baker A, Keshet E, Lupu F, Herbert J, Smits J, Shapiro S, Baes M, Borgers M, Collen D, Daemen MJ, and Carmeliet P. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 5: 1135-1142, 1999.
10. Heymans S, Lupu F, Terclavers S, Vanwetswinkel B, Herbert J, Baker A, Collen D, Carmeliet P, and Moons L. Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice. Am J Pathol 166: 15-25, 2005.
11. Hoppeler H and Kayar SR. Capillary and oxidative capacity of muscles. News Physiol Sci 3: 113-116, 1988.
12. Hughes SE. Detection of apoptosis using in situ markers for DNA strand breaks in the failing human heart. Fact or epiphenomenon? J Pathol 201: 181-186, 2003.
13. Hunt MJ, Aru GM, Hayden MR, Moore CK, Hoit BD, and Tyagi SC. Induction of oxidative stress and disintegrin metalloproteinase in human heart end-stage failure. Am J Physiol Lung Cell Mol Physiol 283: L239-L245, 2002.
14. Jessup M and Brozena S. Heart failure. N Engl J Med 348: 2007-2018, 2003.
15. Kawaguchi N, Xu X, Tajima R, Kronqvist P, Sundberg C, Loechel F, Albrechtsen R, and Wewer U. ADAM 12 protease induces adipogenesis in transgenic mice. Am J Pathol 160: 1895-1903, 2002.
16. Kiatchoosakun S, Kirkpatrick D, and Hoit BD. Effects of tribromoethanol anesthesia on echocardiographic assessment of left ventricular function in mice. Comp Med 51: 26-29, 2001.
17. Kumar D and Jugdutt B. Apoptosis and oxidants in the heart. J Lab Clin Med 142: 288-297, 2003.
18. Lee R. Matrix metalloproteinase inhibition and the prevention of heart failure. Trends Cardiovasc Med 11: 202-205, 2001.
19. Mebazaa A, Wetzel R, Cherian M, and Abraham M. Comparison between endothelial and great vessel endothelial cells: morphology, growth, and prostaglandin release. Am J Physiol Heart Circ Physiol 268: H250-H259, 1995.
20. Michel JB, Salzmann JL, Nlom MO, Bruneval P, Barres D, Camilleri JP. Morphometric analysis of collagen network and plasma perfused capillary bed in the myocardium of rats during evolution of cardiac hypertrophy. Basic Res Cardiol 81: 142-154, 1986.
21. Moshal KS, Tyagi N, Henderson B, Ovechkin AV, and Tyagi SC. Protease activated receptor and endothelial-myocyte uncoupling in chronic heart failure. Am J Physiol Heart Circ Physiol 288: H2770-H2777, 2005.
22. Mujumdar VS, Aru GM, and Tyagi SC. Induction of oxidative stress by homocyst(e)ine impairs endothelial function. J Cell Biochem 82: 491-500. 2001.
23. Mujumdar VS and Tyagi SC. Temporal regulation of extracellular matrix components in transition from compensatory hypertrophy to decompensatory heart failure. J Hypertens 17: 261-270, 1999.
24. Poelzing S and Rosenbaum D. Altered connexin-43 expression produces arrhythmia substrate in heart failure. Am J Physiol Heart Circ Physiol 287: H1762-H1770, 2004.
25. Rodriguez M and Schaper J. Apoptosis: measurement and technical issues. J Mol Cell Cardiol 38: 15-20, 2005.
26. Romanic A, Harrison S, Bao W, Burns-Kurtis C, Pickering S, Gu J, Mao J, Sathe G, Ohlstein E, and Yue T. Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9. Cardiovasc Res 54: 549-558, 2002.
27. Tyagi SC. Dynamic ECM remodeling in the heart failure: cardiac hypertrophy, dilatation and fibrosis. Pathophysiology 4: 227-234, 1997.
28. Tyagi SC, Haas SJ, Kumar SG, Reddy HK, Voelker DJ, Hayden MR, Demmy TL, Schmaltz RA and Curtis JJ. Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy. J Mol Cell Cardiol 28: 1415-1428, 1996.
29. Tyagi SC, Matsubara L, and Weber KT. Direct extraction and estimation of callagenase(s) activity by zymography in microquantities of rat myocardium and uterus. Clin Biochem 26: 191-198, 1993.
30. Yaoita H, Ogawa K, Maehara K, and Maruyama Y. Apoptosis in relevant clinical situations: contribution of apoptosis in myocardial infarction. Cardiovasc Res 45: 730-641, 2000.
31. Ziori C, Zioris C, and Kyriakidis M. Apoptosis in heart failure. Hellenic J Cardiol 44: 56-70, 2003. 2406-2415